• Home
  • Science
    • ImmunoBody®
    • Moditope®
    • Glymab®
    • Publications
  • Pipeline
  • News
  • Investors
    • Share Info
    • Financial Info
    • Documents & Presentations
    • Corporate Governance
  • Contact Us
    • Find a trial
    • Become an Investigator

AACR (American Association for Cancer Research) Annual Meeting, April 2026, San Diego, California

by chantal | Jun 3, 2026 | Immunobody, iSCIB1+, SCIB1

Joseph Chadwick, Samantha Paston, Kate Young, Heather Shaw, Pippa Corrie, Sarah Danson, Miranda Payne, Poulam Patel, Maria Marples, Ioannis Karydis, Satish Kumar, Clare Barlow, Rebecca Leigh, Martin Highley, Kellati Prasad, Olivia Howard, Georgia Goodhew, Joe...

SCOPE Phase 2 Trial Data Update, ESMO December 2025

by chantal | Dec 11, 2025 | Immunobody, iSCIB1+, SCIB1, Vaccines

SCOPE Study Poster, ESMO Immuno-Oncology Congress December 2025

by chantal | Dec 9, 2025 | Immunobody, iSCIB1+, SCIB1

Heather Shaw, Poulam Patel, Miranda Payne, Satish Kumar, Sarah Danson, Martin Highley, Clare Barlow, Kellati Prasad, Ioannis Karydis, Maria Marples, Kate Young, Pippa Corrie, Robert Miller, Georgia Goodhew, Samantha Paston, Gaelle Cane, Joe Chadwick, Lindy Durrant and...

SCOPE Study Presentation, SITC (Society for Immunotherapy of Cancer) Annual Meeting, November 2025, National Harbor, MD

by chantal | Nov 7, 2025 | Immunobody, iSCIB1+, SCIB1, Vaccines

AACR (American Association for Cancer Research) Annual Meeting, April 2025, Chicago, Illinois

by alex | May 2, 2025 | Immunobody, SCIB1

Heather Shaw, Poulam Patel, Miranda Payne, Satish Kumar, Sarah Danson, Martin Highley, Clare Barlow, Kellati Prasad, Ioannis Karydis, Maria Marples,Kate Young, Pippa Corrie, Robert Miller, Georgia Goodhew, Samantha Paston, Gaelle Cane, Joe Chadwick, Lindy Durrant and...

AACR 10 (American Association for Cancer Research), February 2025, Los Angeles, California

by chantal | Mar 12, 2025 | Immunobody, SCIB1

Joseph Chadwick, Gaëlle Cane, Sabaria Shah, Katie Mann, Patrick Copeland, Daisy Weston, Jordan Wright, Leanne Toon, Heather Shaw, Poulam Patel, Miranda Payne, Satish Kumar, Sarah Danson, Martin Highley, Clare Barlow, Kellati Prasad, Ioannis Karydis, Maria Marples,...
« Older Entries

Recent Posts

  • Active Immunotherapy: Ready For Prime Time
  • Strategic transactions to unlock longer-term value
  • Scancell and Neuphoria Therapeutics Announce Merger Agreement and Financing
  • iSCIB1+ pivotal trial plans advancing
  • AACR (American Association for Cancer Research) Annual Meeting, April 2026, San Diego, California

Recent Comments

No comments to show.

Scancell is focused on developing novel immunotherapies for the treatment of cancer and was founded in 1996 based on research led by Professor Lindy Durrant at the University of Nottingham in the UK.

  • Follow
  • Follow

Science
Our Pipeline
News
Contact Us
Find a Trial
Become an Investigator

ACTIVE IMMUNOTHERAPY

ImmunoBody®
Moditope®

ANTIBODIES

GlyMab®
AvidiMab®

Investors
Company Profile
Advisors
Corporate Governance
Documents & Presentations
Share Information
Financial Information

Copyright © 2026 Scancell | Website Designed & Developed by Identity Creative | Privacy & Cookie Policy